XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Mar. 31, 2023 6,271,971      
Balance at Mar. 31, 2023 $ 125 $ 33,856 $ (17,634) $ 16,347
Issuances of common stock for Directors Stock Grants (in shares) 159,493      
Issuances of common stock for Directors Stock Grants $ 3 123 0 126
Issuances of common stock to Directors in lieu of cash for prior year board fees (in shares) 17,672      
Issuances of common stock to Directors in lieu of cash for prior year board fees $ 0 15 0 15
Issuances of vested shares of restricted stock (in shares) 37,996      
Issuances of vested shares of restricted stock $ 1 (12) 0 (11)
Shares withheld for tax payments (in shares) (13,353)      
Shares withheld for tax payments $ 0 0 0 0
Share-based compensation expense 0 96 0 96
Net income (loss) 0 0 (2,166) (2,166)
Net loss $ 0 0 (2,166) (2,166)
Balance (in shares) at Sep. 30, 2023 6,473,779      
Balance at Sep. 30, 2023 $ 129 34,078 (19,800) 14,407
Balance (in shares) at Jun. 30, 2023 6,291,086      
Balance at Jun. 30, 2023 $ 126 33,917 (19,003) 15,040
Issuances of common stock for Directors Stock Grants (in shares) 159,493      
Issuances of common stock for Directors Stock Grants $ 3 123 0 126
Issuances of vested shares of restricted stock (in shares) 35,718      
Issuances of vested shares of restricted stock $ 0 (11) 0 (11)
Shares withheld for tax payments (in shares) (12,518)      
Shares withheld for tax payments $ 0 0 0 0
Share-based compensation expense 0 49 0 49
Net income (loss) 0 0 (797) (797)
Net loss $ 0 0 (797) (797)
Balance (in shares) at Sep. 30, 2023 6,473,779      
Balance at Sep. 30, 2023 $ 129 34,078 (19,800) 14,407
Balance (in shares) at Mar. 31, 2024 6,947,246      
Balance at Mar. 31, 2024 $ 139 34,576 (22,901) 11,814
Issuances of common stock for Directors Stock Grants (in shares) 116,049      
Issuances of common stock for Directors Stock Grants $ 2 92 0 94
Issuances of common stock to Directors in lieu of cash for current year board fees (in shares) 13,334      
Issuances of common stock to Directors in lieu of cash for current year board fees $ 0 10 0 10
Issuances of common stock to Directors in lieu of cash for prior year board fees (in shares) 53,333      
Issuances of common stock to Directors in lieu of cash for prior year board fees $ 1 39 40
Issuances of vested shares of restricted stock (in shares) 20,456      
Issuances of vested shares of restricted stock $ 1 (5) 0 (4)
Shares withheld for tax payments (in shares) (7,718)      
Shares withheld for tax payments $ 0 0 0 0
Share-based compensation expense 0 90 0 90
Net income (loss) 0 0 (2,352) (2,352)
Net loss $ 0 0 (2,352) (2,352)
Balance (in shares) at Sep. 30, 2024 7,142,700      
Balance at Sep. 30, 2024 $ 143 34,802 (25,253) 9,692
Balance (in shares) at Jun. 30, 2024 6,948,379      
Balance at Jun. 30, 2024 $ 139 34,624 (24,103) 10,660
Issuances of common stock for Directors Stock Grants (in shares) 116,049      
Issuances of common stock for Directors Stock Grants $ 2 92 0 94
Issuances of common stock to Directors in lieu of cash for current year board fees (in shares) 13,334      
Issuances of common stock to Directors in lieu of cash for current year board fees $ 0 10 0 10
Issuances of common stock to Directors in lieu of cash for prior year board fees (in shares) 53,333      
Issuances of common stock to Directors in lieu of cash for prior year board fees $ 1 39 40
Issuances of vested shares of restricted stock (in shares) 18,608      
Issuances of vested shares of restricted stock $ 1 (5) 0 (4)
Shares withheld for tax payments (in shares) (7,003)      
Shares withheld for tax payments $ 0 0 0 0
Share-based compensation expense 0 42 0 42
Net income (loss) 0 0 (1,150) (1,150)
Net loss $ 0 0 (1,150) (1,150)
Balance (in shares) at Sep. 30, 2024 7,142,700      
Balance at Sep. 30, 2024 $ 143 $ 34,802 $ (25,253) $ 9,692